As the increased activity of BACE1 and increased expression of p53 with altered conformation are observed in brain of patients with sporadic AD, we hypothesized whether CHIP would destabilize BACE1 via proteasomal degradation and whether it could stabilize p53 to trans-repress BACE1 gene transcription. The gene discussed is TP53; the disease is Alzheimer disease.